Table 5. Diagnostic modalities and their role in diseases of the visual system.
| Migraine | Epilepsy | Ischemia | VSS | HPPD | CBS | |
| cMRI | – | Mandatory | Mandatory, with ‧vi‧sualization of vessels | Single scan ‧indicated | Single scan ‧indicated | Single scan ‧indicated |
| EEG | DbA | Indicated | – | ? | DbA | DbA |
| VEP | – | – | – | ? | DbA | – |
| Sight testing | – | – | In CRAO | Indicated | Indicated | Indicated |
| Perimetry | Indicated at first occurrence and in presence of persistent symptoms; homonymous defect during aura | – | In CRAO | DbA | DbA | Indicated |
| Funduscopy | – | – | In CRAO | DbA | Indicated | |
| Treatment | Specific treatment rarely necessary; migraine prophylaxis if indicated | Multiple | Systemic lysis in acute phase, otherwise secondary prevention | Explanation; trial of lamotrigine if indicated | In some cases ‧anticonvulsants, benzodiazepines, and neuroleptics | Explanation; ‧anticonvulsants and neuroleptics if ‧indicated |
| Specialty | Neurology | Neurology | Neurology,ophthalmology | Neurology | Psychiatry | Ophthalmology |
CBS, Charles Bonnet syndrome; cMRI, cranial magnetic resonance imaging; CRAO, central retinal artery occlusion; DbA, diagnosis by exclusion; EEG, electroencephalography; HPPD, hallucinogen persisting perception disorder; VEP, visual evoked potential; VSS, visual snow syndrome; –, not indicated; ?, role unclear